Structural Biology of Human H3K9 Methyltransferases
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
UNLABELLED: SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity. ENHANCED VERSION: This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Phylogenetic tree of human histone methyltransferases. Phylogeny is based on a multiple sequence alignment of the methyltransferase domain including the N-SET, Pre_SET, SET, I-SET, and Post-SET motifs. Substrate selectivity was extracted from Kouzarides [1]. Enzymes with solved structure are highlighted by a frame, dotted if no peptide substrate complex is available. Structures solved in the present work are framed in red.](https://figures.cochat.ai/paper-figures/f223740273dd4504943d435b9d71af7c/structural-biology-of-human-h3k9-methyltransferases-figure-1.jpg)

![Figure 3 Structural determinants of G9a mono/di-methylation specificity. A model of substrate lysine-bound G9a (Top panel) was generated from the superposition of the active sites of the GPL ternary complex and GLP. Y1067 of G9a stabilizes the di-methylamine end of the substrate lysine in an orientation where the lone-pair is not facing the co-factor, thereby disfavoring transfer of a third methyl group. The Y1067F mutant loses this restriction and can tri-methylate its substrate, as indicated in the table. Previous work had shown that the F1152Y G9a mutant can only mono-methylate H3K9 [29].](https://figures.cochat.ai/paper-figures/ecf8fd2d2aa84552bf80a968a979ba0d/structural-biology-of-human-h3k9-methyltransferases-figure-3.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2008) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,804 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“Graphics program COOT [36] was used for model building and PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8570 T a b le 1 .”
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903 · cited 1×
“. Tri-methylation of lysine 9 of histone 3 (H3K9) mediates chromatin recruitment of HP1, heterochromatin condensation and gene silencing”
BackgroundMethylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057 · cited 2×
“Methylation of histone tails is one of the fundamental events of epigenetic signaling [3].”
BackgroundSubstructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588 · cited 1×
“PRDM2 structure was solved by single-wavelength anomalous diffraction (SAD) at low resolution, using a selenomethionine derivative crystal with the program SHELXD [37], and the phasing was performed using SHELXE [38].”
MethodPartitioning and Plasticity of Repressive Histone Methylation States in Mammalian Chromatin
Peters, A. H. F. M., Kubicek, S., Mechtler, K., O'Sullivan, R. J., Derijck, A. A. H. A., Perez-Burgos, L., Kohlmaier, A., Opravil, S., Tachibana, M., Shinkai, Y., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00477-5 · Cited by 1,152 · cited 1×
“The specificity of PRDM2 is unknown [25].”
Heterochromatin and Epigenetic Control of Gene Expression
Grewal, S. I. S., & Moazed, D. (2003) · Science · doi:10.1126/science.1086887 · Cited by 1,065 · cited 1×
“Post-translational modifications of histone proteins regulate chromatin compaction, mediate epigenetic regulation of transcription, and control cellular differentiation in health and disease [1,2].”
BackgroundThe SET-domain protein superfamily: protein lysine methyltransferases.
Dillon, S. C., Zhang, X. Y., Trievel, R. C., & Cheng, X. (2005) · Genome biology · doi:10.1186/gb-2005-6-8-227 · Cited by 978 · cited 1×
“HKMTs catalyze the transfer of a methyl group from the co-factor S-adenosyl-Lmethionine (SAM) to a substrate lysine and, with the exception of DOT1L, are all organized around a canonical SET domain [7,8].”
BackgroundShi, Y., Desponts, C., Do, J. T., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.004 · Cited by 902 · cited 1×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundAn approach to multi-copy search in molecular replacement
Vagin, A., & Teplyakov, A. (2000) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900013780 · Cited by 706 · cited 1×
“The structures of methyltransferase domain of GLP, G9a, and SUV39H2 were solved by molecular replacement using the program MOLREP [34].”
MethodMultiparametric scaling of diffraction intensities
Otwinowski, Z., Borek, D., Majewski, W., & Minor, W. (2003) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767303005488 · Cited by 656
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550 · cited 1×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundProtein methyltransferases as a target class for drug discovery
Copeland, R. A., Solomon, M. E., & Richon, V. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2974 · Cited by 460 · cited 1×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundARP/wARP and molecular replacement
Perrakis, A., Harkiolaki, M., Wilson, K. S., & Lamzin, V. S. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901014007 · Cited by 455 · cited 1×
“ARP/wARP [35] was used for automatic model building.”
Chemical mechanisms of histone lysine and arginine modifications
Smith, B. C., & Denu, J. M. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.06.005 · Cited by 390 · cited 6×
“E - SETD7-TAF10 and SETD7-P53 complexes not shown).”
BackgroundInfluentialStructure and catalytic mechanism of the human histone methyltransferase SET7/9
Xiao, B., Jing, C., Wilson, J. R., Walker, P. A., Vasisht, N., Kelly, G., Howell, S., Taylor, I. A., Blackburn, G. M., & Gamblin, S. J. (2003) · Nature · doi:10.1038/nature01378 · Cited by 383
Li, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Protein lysine methyltransferase G9a acts on non-histone targets
Rathert, P., Dhayalan, A., Murakami, M., Zhang, X., Tamas, R., Jurkowska, R., Komatsu, Y., Shinkai, Y., Cheng, X., & Jeltsch, A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.88 · Cited by 347 · cited 1×
“This is in agreement with recent mutational analysis showing that no substitution at position -1 is tolerated by G9a [30].”
ResultStructural and Sequence Motifs of Protein (Histone) Methylation Enzymes
Cheng, X., Collins, R. E., & Zhang, X. (2005) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.34.040204.144452 · Cited by 347 · cited 1×
“The Suv39 structures G9a, GLP and SUV39H2 adopt a typical fold composed of a conserved SET domain and variable I-SET insert, flanked by Pre- and Post-SET regions, and characterized by canonical features such as a pseudoknot next to the catalytic site, distinct co-factor and substrate binding areas meeting at the site…”
BackgroundStructural Basis for the Product Specificity of Histone Lysine Methyltransferases
Zhang, X., Yang, Z., Khan, S. I., Horton, J. R., Tamaru, H., Selker, E. U., & Cheng, X. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00224-7 · Cited by 329 · cited 10×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundInfluentialSET domain protein lysine methyltransferases: Structure, specificity and catalysis
Qian, C., & Zhou, M. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6274-5 · Cited by 313 · cited 6×
“As previously observed with other HKMTs ([9,11,8] for review), the co-factor contributes to the formation of a hydrophobic, mostly aromatic cluster (composed of Post-SET Y1211/Y1154/Y261, F1215/F1158, W1216/W1159/L298, F1223/F1166/T285 and SET H1170/H1113/H220 in GLP/ G9a/SUV39H2) necessary for partial folding of the…”
BackgroundInfluentialStructural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
Unsafe SETs: histone lysine methyltransferases and cancer
Schneider, R., Bannister, A. J., & Kouzarides, T. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02141-2 · Cited by 287 · cited 1×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundStructure of the Neurospora SET Domain Protein DIM-5, a Histone H3 Lysine Methyltransferase
Zhang, X., Tamaru, H., Khan, S. I., Horton, J. R., Keefe, L. J., Selker, E. U., & Cheng, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00999-6 · Cited by 249 · cited 7×
“The Post-SET domains of G9a, GLP, SUV39H2, but not PRDM2 include a ZnCys motif previously observed in the structures of Dim-5 [13] and the H3K4 methyltransferase MLL1 [10].”
BackgroundInfluentialSouthall, S. M., Wong, P.-S., Odho, Z., Roe, S. M., & Wilson, J. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.029 · Cited by 228 · cited 5×
“This implies that Post-SET is naturally flexible, which may be important for peptide turn-over, as recently proposed [10].”
BackgroundInfluentialStructural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase
Couture, J.-F., Collazo, E., Brunzelle, J. S., & Trievel, R. C. (2005) · Genes & Development · doi:10.1101/gad.1318405 · Cited by 220 · cited 11×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundInfluentialThe control of histone lysine methylation in epigenetic regulation
Völkel, P., & Angrand, P.-O. (2007) · Biochimie · doi:10.1016/j.biochi.2006.07.009 · Cited by 195 · cited 2×
“Methylation of H3K9 in humans relies mostly on members of the Suv39 family, namely EHMT1/GLP, EHMT2/G9a, SUV39H1, SUV39H2, SETDB1 and SETDB2, as well as then non-Suv39 enzymes PRDM2 and ASH1L [6] (Figure 1).”
BackgroundGonzalez, M. E., Li, X., Toy, K., DuPrie, M., Ventura, A. C., Banerjee, M., Ljungman, M., Merajver, S. D., & Kleer, C. G. (2009) · Oncogene · doi:10.1038/onc.2008.433 · Cited by 195 · cited 1×
“). Here we report the high-resolution crystal structures of the methyltransferase domains of GLP, G9a, SUV39H2 and PRDM2, and propose a structural mechanism for substrate recognition. Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have…”
BackgroundCollins, R. E., Tachibana, M., Tamaru, H., Smith, K. M., Jia, D., Zhang, X., Selker, E. U., Shinkai, Y., & Cheng, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410483200 · Cited by 189 · cited 2×
“Similarly, it was shown that the F1152Y G9a mutant can only mono-methylate H3K9 [29].”
BackgroundSpecificity and mechanism of the histone methyltransferase Pr-Set7
Xiao, B., Jing, C., Kelly, G., Walker, P. A., Muskett, F. W., Frenkiel, T. A., Martin, S. R., Sarma, K., Reinberg, D., Gamblin, S. J., et al. (2005) · Genes & Development · doi:10.1101/gad.1315905 · Cited by 185 · cited 4×
“Several aromatic residues line the GLP channel occupied by the substrate lysine leading to the catalytic site and contribute to methylation state specificity as previously noted for several other HKMTs [9,12,26,27].”
BackgroundInfluentialThe Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Spannhoff, A., Hauser, A., Heinke, R., Sippl, W., & Jung, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900301 · Cited by 171 · cited 1×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundSET domains and histone methylation
Xiao, B., Wilson, J. R., & Gamblin, S. J. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.003 · Cited by 163 · cited 1×
“The Suv39 structures G9a, GLP and SUV39H2 adopt a typical fold composed of a conserved SET domain and variable I-SET insert, flanked by Pre- and Post-SET regions, and characterized by canonical features such as a pseudoknot next to the catalytic site, distinct co-factor and substrate binding areas meeting at the site…”
BackgroundStructure of SET domain proteins: a new twist on histone methylation
Marmorstein, R. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00007-0 · Cited by 128 · cited 1×
“These structures collectively highlighted a remarkable plasticity of the peptide-binding site and a lack of clear structural motifs that correlate with sequence selectivity [8,15].”
BackgroundA coupled fluorescent assay for histone methyltransferases
Collazo, E., Couture, J., Bulfer, S. L., & Trievel, R. C. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.007 · Cited by 117 · cited 1×
“[39] was optimized and employed to assay the activity of G9a.”
MethodStructural origins for the product specificity of SET domain protein methyltransferases
Couture, J.-F., Dirk, L. M. A., Brunzelle, J. S., Houtz, R. L., & Trievel, R. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806712105 · Cited by 112 · cited 10×
“Our data also provide important insight to guide the development of potent and selective inhibitors of HKMTs, which are likely to have applications in a variety of diseases including regenerative medicine, oncology and inflammation [16,17,18,19,20] ([21,22] for review).”
BackgroundInfluentialRathert, P., Zhang, X., Freund, C., Cheng, X., & Jeltsch, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.013 · Cited by 86 · cited 1×
“crassa [31], indicating that the selectivity mechanism observed for human GLP and G9a is not universal.”
BackgroundQian, C., Wang, X., Manzur, K. L., Sachchidanand, Farooq, A., Zeng, L., Wang, R., & Zhou, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.006 · Cited by 67 · cited 4×
“Similarly, methylation of H3K27 and H4K20 are associated with a repressed state of chromatin, whereas expressed genes are methylated at H3K4, H3K36 and H3K79 ([3,6] for review).”
BackgroundInfluential
Cited by
Sneeringer, C. J., Scott, M. P., Kuntz, K. W., Knutson, S. K., Pollock, R. M., Richon, V. M., & Copeland, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012525107 · Cited by 683
“Similarly, the wild-type enzyme G9a can dimethylate H3K9 but is unable to perform the di- to trimethylation reaction.”
BackgroundInfluentialYap, D. B., Chu, J., Berg, T., Schapira, M., Cheng, S.-W. G., Moradian, A., Morin, R. D., Mungall, A. J., Meissner, B., Boyle, M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 606
“Biotinylated peptides, H3 (1-21) (#12-403), H3 (21-44) (#12-404), H3(21-44)K27(me1) (#12-567), H3(21-44)K27(me2) (#12566), and H3(21-44)K27(me3) (#12-565), were purchased from Upstate Biotechnology.”
Self-citationPadeken, J., Methot, S. P., & Gasser, S. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00483-w · Cited by 514
McCabe, M. T., Graves, A. P., Ganji, G., Diaz, E., Halsey, W. S., Jiang, Y., Smitheman, K. N., Ott, H. M., Pappalardi, M. B., Allen, K. E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116418109 · Cited by 483
“Similarly, exchange of the Y641 equivalent in the H3K9 methyltransferase G9a (Y1067) for phenylalanine converts the enzyme from a mono- and dimethyltransferase to a trimethyltransferase (38).”
BackgroundStruck, A., Thompson, M. L., Wong, L. S., & Micklefield, J. (2012) · ChemBioChem · doi:10.1002/cbic.201200556 · Cited by 430
Metadata
- Authors
- Wu, H., Min, J., Lunin, V. V., Antoshenko, T., Dombrovski, L., Zeng, H., Allali-Hassani, A., Campagna-Slater, V., Vedadi, M., Arrowsmith, C. H., Plotnikov, A. N., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Plotnikov, Alexander N.
- Schapira, Matthieu
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-01-11
- Volume
- 5
- Issue
- 1
- Pages
- e8570
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2797608
- OpenAlex
- W2106473601
- Cited by
- 268
- References
- 39
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 11 · 2023: 14 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 14 · 2017: 14 · 2016: 16 · 2015: 24 · 2014: 20 · 2013: 17 · 2012: 21
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- GlaxoSmithKline
- Ontario Innovation Trust
- Genome Canada (1097737)
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Stiftelsen för Strategisk Forskning
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- H3K9 methyltransferase, SET domain, G9a, GLP, SUV39H2, PRDM2, histone methylation, epigenetic regulation, S-adenosylmethionine, induced fit, electrostatic interactions, protein structure
- MeSH terms
- Histone Methyltransferases, Crystallization, Humans, Models, Molecular, Protein Conformation, Histone-Lysine N-Methyltransferase, Substrate Specificity, Catalytic Domain, Static Electricity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.